Cannabis Conundrum: Demonstrating “Accepted Medical Use” in a Restricted Research Environment October 7, 2020 Delia Deschaine Federal 0 Comments By Delia Ann Deschaine and Megan Robertson U.S. cannabis businesses operate in an increasingly complex legal and regulatory environment. Many, if not most, of those complexities stem from marijuana’s classification in Schedule I of the federal Controlled Substances Act. That… Read More→